X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Rising care costs Regeneron Pharmaceuticals Inc. and Sanofi said they would deeply discount their $14,000-a-year cholesterol treatment to $4,500 to $8,000 for some patients in order to loosen insurer restriction on the drugs. (Photo: Shutterstock)

Drugmakers tried just about every move under the sun to nurture sales of its products — pharmacy coupons for patients, exclusive deals with insurers, even selling a medicine’s patent to a Native American tribe to shield it from a legal challenge.

BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now

Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.